tiprankstipranks
Humana (CH:HUM)
NYSE:HUM

Humana (HUM) Price & Analysis

3 Followers

HUM Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

Bulls Say, Bears Say

Bulls Say
Medicare Advantage GrowthSustained membership expansion in Medicare Advantage increases premium volume, improves risk pooling, and strengthens negotiating leverage with providers. A growing MA base supports diversified revenue and scale benefits that persist through the 2–6 month horizon and underpin longer-term profitability targets.
CenterWell ExpansionRapid CenterWell patient growth and M&A deepen Humana’s provider footprint and vertical integration, improving care coordination and value-based care execution. Owning more care delivery assets can sustainably lower medical cost per member and diversify service revenue over time.
Enhanced Liquidity & Funding OptionsPre-capitalized trusts and note issuances provide committed contingent capital and reduce near-term refinancing risk. These structural liquidity moves strengthen Humana’s funding flexibility for reserve needs, benefit offtakes, or strategic investments over the medium term without immediate debt on the balance sheet.
Bears Say
Compressed ProfitabilityMaterial margin compression reduces Humana’s earnings buffer against cost shocks and weakens ROE, making the business more sensitive to utilization or price swings. Persistently low margins constrain reinvestment and increase the reliance on price discipline and structural fixes to restore long-term profitability.
Weak Cash ConversionLower and volatile free cash flow conversion limits Humana’s ability to fund capital, absorb reserve shocks, or pursue opportunistic M&A without external financing. Over months this reduces strategic optionality and increases sensitivity to funding market conditions if operating volatility continues.
Medical Cost Trend & Reserving PressureStructural medical-cost inflation and elevated IBNR create persistent margin pressure and force pricing, benefit adjustments, or higher reserves. A larger 2027 funding gap raises the likelihood of tougher bids or benefit changes, which can erode member economics and revenue stability over the medium term.

Humana News

HUM FAQ

What was Humana’s price range in the past 12 months?
Currently, no data Available
What is Humana’s market cap?
Humana’s market cap is CHF36.59B.
    When is Humana’s upcoming earnings report date?
    Humana’s upcoming earnings report date is Jul 29, 2026 which is in 33 days.
      How were Humana’s earnings last quarter?
      Humana released its earnings results on Apr 29, 2026. The company reported $8.225 earnings per share for the quarter, beating the consensus estimate of $8.173 by $0.052.
        Is Humana overvalued?
        According to Wall Street analysts Humana’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Humana pay dividends?
          Humana does not currently pay dividends.
          What is Humana’s EPS estimate?
          Humana’s EPS estimate is 5.76.
            How many shares outstanding does Humana have?
            Currently, no data Available
            What happened to Humana’s price movement after its last earnings report?
            Humana reported an EPS of $8.225 in its last earnings report, beating expectations of $8.173. Following the earnings report the stock price went same N/A.
              Which hedge fund is a major shareholder of Humana?
              Currently, no hedge funds are holding shares in CH:HUM
              What is the TipRanks Smart Score and how is it calculated?
              Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                Company Description

                Humana

                Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.

                Humana (HUM) Earnings & Revenues

                HUM Earnings Call

                Q1 2026
                0:00 / 0:00
                Earnings Call Sentiment|Positive
                The call conveyed constructive progress on strategic priorities — membership growth, CenterWell expansion, balance sheet improvements, operational transformation, and measured Stars progress — while candidly acknowledging persistent headwinds: medical cost trend outpacing funding, elevated early-year reserves, potential put-option cash exposure, and the need to consider benefit adjustments in 2027. Management emphasized prudence in reserving, disciplined bidding, and multiple levers (operational improvements, M&A, pricing) to meet the 2028 margin objective.View all CH:HUM earnings summaries

                HUM Revenue Breakdown

                94.73%94.73%4.50%0.78%
                94.73% Premiums
                4.50% Services
                0.78% Investment income
                tipranks

                HUM Stock 12 Month Forecast

                Average Price Target

                $239.06
                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
                Similar Stocks
                Company
                Price & Change
                Follow
                Centene
                Cigna
                Molina Healthcare
                UnitedHealth
                Elevance Health

                Options Prices

                Currently, No data available
                ---
                Popular Stocks